A Trusted Partner Providing
Reliable Information on Medicines

  • slide
  • slide
  • slide
  • slide
App Store Google Play

News


Aug 30, 2023, 11:21 AM

Prolongation of the QT interval is a well-established risk factor that predicts increased mortality from sudden cardiac death.1 Identification of patients with the highest risk of QT prolongation and associated adverse outcomes has been facilitated…

View post
Jun 26, 2023, 7:26 PM

AZCERT's Scientific Review Committee has found substantial evidence that Pacritinib (anticancer), Vernakalant (antiarrhythmic) and Fexinidazole (antiparasitic) are associated with the development of QT prolongation but lack convincing evidence…

View post
Mar 21, 2023, 2:28 PM

AZCERT values and respects the trust so many have placed in CredibleMeds.org and MedSafetyScan.org. We always seek your advice on how AZCERT can better fulfil its mission to improve the safe use of medicines.

View post
Feb 22, 2023, 6:23 PM

AZCERT's Scientific Review Committee has found substantial evidence that Macimorelin (used for diagnosis of growth hormone deficiency),  Dexmedetomidine (sedative), Pralsetinib (Thyroid cancer), Adagrasib (NSC Lung cancer) and Tebentafusp ...

View post
Nov 17, 2022, 10:08 AM

At the heart of the ADECA process that is used to maintain the QTdrugs List is the active and passive surveillance of data for the thousands of prescription drugs  available  in the United States. We analyze this constant stream of new data to keep…

View post

Text for citing the use of the QTdrugs List or the CredibleMeds.org website:

Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA,  www.CredibleMeds.org,  QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ  85718

 

Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.

x